Category: Generics Drugs
South Korea Generics Drugs
-
Asia Pacific Multiple Sclerosis Drugs Market, By Disease Type (Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing-Remitting Multiple Sclerosis (RES)); By Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies); By Drug Type (Branded, Generic); By End User (Hospital & Clinics, Diagnostic Laboratories); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029
... End User (Pharmaceutical & Biopharmaceutical Companies, Labs & Research Institutes, Healthcare Providers, Healthcare Payers); By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis); By Region (North America, Europe, Asia ... Read More
-
South Korea Generics Market Summary, Competitive Analysis and Forecast to 2027
... profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is defined as a ... Read More
-
Impact of South Korea on the Pharmaceutical Industry - Thematic Intelligence
... South Korea is a market that offers significant potential for big pharma manufacturing, with domestic companies dominating the marketed product landscape as encouraged by government policy. The top three therapy areas among marketed and pipeline ... Read More
-
South Korea Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
... to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights For the purposes of this profile, a generic drug is ... Read More
Research Assistance
